Waltham-based BG Medicine Inc. announced the pricing in a sale of nearly 6.5 million shares of its common stock in an underwritten public offering. The price to the public is $1.55 per share. Net proceeds are expected to be $8.9 million and may be used for operations, including advancing the commercialization of its cardiovascular diagnostic tests in the United States and Europe and expanding its product pipeline.
BG Medicine prices at $1.55 in offering
